Synovial sarcoma is a rare, aggressive malignancy with deceptive benign presentation, complicating diagnosis and delaying treatment. Molecular confirmation of SS18-SSX fusion genes is crucial for ...
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...
FDA orphan drug designation provides incentives including regulatory support, tax credits, fee exemptions, and seven years of ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
Second Diagnostic Opinions in Sarcoma Linked to Improved Survival Outcomes Phase 2 trial results show anlotinib with anthracyclines and ifosfamide yields a 30.8% ORR and an 82.7% DCR in advanced soft ...
Radiation-Associated Sarcoma in a Resource-Constrained Setting: A Decade of Real-World Outcomes From a Tertiary Care Sarcoma Center in India This study illustrates a pragmatic model for implementing ...
Recent advancements in medical technology have revolutionized limb-salvage surgery and functional reconstruction for pediatric bone and soft tissue tumors. These innovations not only help in limb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results